[1]
Vrankar, M., Stanic, K., Jelercic, S., Ciric, E., Vodusek, A.L. and But-Hadzic, J. 2021. Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy – single institute experience. Radiology and Oncology. 55, 4 (Dec. 2021), 482–490.